Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.

Authors :: de Boer, Rudolf A.
Siebelink, Hans-Marc J.
Tio, René A.
Boomsma, Frans
van Veldhuisen, Dirk J.
de Boer, R A
Siebelink, H J
Tio, R A
Boomsma, F
van Veldhuisen, D J
Source :: European Journal of Heart Failure; Jun2001, Vol. 3 Issue 3, p331-333, 3p
Publication Year :: 2001
Abstract: The article presents a double-blind study on chronic heart failure (CHF) patients to determine the effects of carvedilol on plasma vascular endothelial growth factor (VEGF). It states that carvedilol or placebo were given randomly to patients, who were treated based on an uptitration schedule. Results show the benefits of beta-blockers in ischemic heart disease (IHD) and CHF. It concludes that CHF patients using carvedilol had increased VEGF.

Subjects :: HEART failure patients
ADRENERGIC beta blockers
VASCULAR endothelial growth factors
BLIND experiment
CORONARY disease

Full Text Access

Tools